Lorenzo G. Quiambao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lorenzo G. Quiambao has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo da Silva Antunes
Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA
2 shared publications Aaron Sutherland
Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, California, USA
1 shared publication- Aaron Sutherland
La Jolla Institute for Immunology, La Jolla, California, USA
1 shared publication - Alba Grifoni
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, USA
1 shared publication - Alena Janda Markmann
Department of Medicine, Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill
1 shared publication Alessandro Sette
Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, California, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 2 October 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6512) , 89-94
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Preexisting immune response to SARS-CoV-2: Robust T cell responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus occur in most individuals with coronavirus disease 2019 (COVID-19). Several studies have reported that some people who have not been exposed to SARS-CoV-2 have preexisting reactivity to SARS-CoV-2 sequences. The immunological mechanisms underlying this preexisting reactivity are not clear, but previous exposure to widely circulating common cold coronaviruses might be involved. Mateus et al. found that the preexisting reactivity against SARS-CoV-2 comes from memory T cells and that cross-reactive T cells can specifically recognize a SARS-CoV-2 epitope as well as the homologous epitope from a common cold coronavirus. These findings underline the importance of determining the impacts of preexisting immune memory in COVID-19 disease severity. Science , this issue p. 89
- 2 October 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6512) , 89-94
Top Cited PapersOpen AccessSelective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Preexisting immune response to SARS-CoV-2: Robust T cell responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus occur in most individuals with coronavirus disease 2019 (COVID-19). Several studies have reported that some people who have not been exposed to SARS-CoV-2 have preexisting reactivity to SARS-CoV-2 sequences. The immunological mechanisms underlying this preexisting reactivity are not clear, but previous exposure to widely circulating common cold coronaviruses might be involved. Mateus et al. found that the preexisting reactivity against SARS-CoV-2 comes from memory T cells and that cross-reactive T cells can specifically recognize a SARS-CoV-2 epitope as well as the homologous epitope from a common cold coronavirus. These findings underline the importance of determining the impacts of preexisting immune memory in COVID-19 disease severity. Science , this issue p. 89
- Open Access
- 1 January 2020
- Published by Wiley in Journal of Immunology Research
- Vol. 2020 (1) , 8202067
Development and Validation of a Bordetella pertussis Whole‐Genome Screening Strategy
The immune response elicited by the protective whole‐cell pertussis (wP) versus the less‐protective acellular pertussis (aP) vaccine has been well characterized; however, important clinical problems remain unsolved, as the inability of the currently administered aP vaccine is resulting in the reemergence of clinical disease (i.e., whooping cough). Strong evidence has shown that original, childhood aP and wP priming vaccines provide a long‐lasting imprint on the CD4+ T cells that impacts protective immunity. However, aP vaccination might prevent disease but not infection, which might also affect the breadth of responses to Bordetella pertussis (BP) antigens. Thus, characterizing and defining novel targets associated with T cell reactivity are of considerable interest. Here, we compare the T cell reactivity of original aP and wP priming for different antigens contained or not contained in the aP vaccine and define the basis of a full‐scale genomic map of memory T cell reactivity to BP antigens in humans. Our data show that the original priming after birth with aP vaccines has higher T cell reactivity than originally expected against a variety of BP antigens and that the genome‐wide mapping of BP using an ex vivo screening methodology is feasible, unbiased, and reproducible. This could provide invaluable knowledge towards the direction of a new and improved pertussis vaccine design.
- 1 January 2020
- Published by Wiley in Journal of Immunology Research
- Vol. 2020 (1) , 8202067
Open AccessDevelopment and Validation of a Bordetella pertussis Whole‐Genome Screening Strategy
The immune response elicited by the protective whole‐cell pertussis (wP) versus the less‐protective acellular pertussis (aP) vaccine has been well characterized; however, important clinical problems remain unsolved, as the inability of the currently administered aP vaccine is resulting in the reemergence of clinical disease (i.e., whooping cough). Strong evidence has shown that original, childhood aP and wP priming vaccines provide a long‐lasting imprint on the CD4+ T cells that impacts protective immunity. However, aP vaccination might prevent disease but not infection, which might also affect the breadth of responses to Bordetella pertussis (BP) antigens. Thus, characterizing and defining novel targets associated with T cell reactivity are of considerable interest. Here, we compare the T cell reactivity of original aP and wP priming for different antigens contained or not contained in the aP vaccine and define the basis of a full‐scale genomic map of memory T cell reactivity to BP antigens in humans. Our data show that the original priming after birth with aP vaccines has higher T cell reactivity than originally expected against a variety of BP antigens and that the genome‐wide mapping of BP using an ex vivo screening methodology is feasible, unbiased, and reproducible. This could provide invaluable knowledge towards the direction of a new and improved pertussis vaccine design.
- Open Access
- 6 May 2016
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 138 (19) , 6107-6110
Tetrahydroxydiboron-Mediated Palladium-Catalyzed Transfer Hydrogenation and Deuteriation of Alkenes and Alkynes Using Water as the Stoichiometric H or D Atom Donor
There are few examples of catalytic transfer hydrogenations of simple alkenes and alkynes that use water as the stoichiometric H or D atom donor. We have found that diboron reagents efficiently mediate the transfer of H or D atoms from water onto unsaturated C–C bonds using a palladium catalyst. This reaction can be conducted on a broad variety of alkenes and alkynes at ambient temperature, on gram scale, using dichloromethane or even water itself as the solvent. Mechanistic experiments suggest that this reaction is made possible by an unprecedented and rate-determining σ-bond metathesis event that generates a Pd–hydride intermediate. Critically, complete deuterium incorporation from stoichiometric D2O is possible.
- 6 May 2016
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 138 (19) , 6107-6110
Open AccessTetrahydroxydiboron-Mediated Palladium-Catalyzed Transfer Hydrogenation and Deuteriation of Alkenes and Alkynes Using Water as the Stoichiometric H or D Atom Donor
There are few examples of catalytic transfer hydrogenations of simple alkenes and alkynes that use water as the stoichiometric H or D atom donor. We have found that diboron reagents efficiently mediate the transfer of H or D atoms from water onto unsaturated C–C bonds using a palladium catalyst. This reaction can be conducted on a broad variety of alkenes and alkynes at ambient temperature, on gram scale, using dichloromethane or even water itself as the solvent. Mechanistic experiments suggest that this reaction is made possible by an unprecedented and rate-determining σ-bond metathesis event that generates a Pd–hydride intermediate. Critically, complete deuterium incorporation from stoichiometric D2O is possible.